| Code | 8993D | ||||||||||
| MA number | 19/0285/21-S | ||||||||||
| Product Form: | tbl flm 30x180 mg (blis.Al/PVC/PVDC) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 19 - ANTIDOTA, DETOXICANTIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 30.11.2021 |
| Validity: | 30.11.2026 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Deferasirox Glenmark 180 mg_360 mg_tbl flm_08_2023.pdf
|
| PIL: |
PIL_Deferasirox Glenmark 180 mg_360 mg_tbl flm_08_2023.pdf
|
| Safety feature | Yes |
| Data update: | 06.12.2021 |
